• Contact Information
• Product Information - NEW: Atazanavir Expanded Access Protocol Synopsis
• Key Personnel

CONTACT INFORMATION

Bristol-Myers Squibb Patient and Community Affairs

Martin C. Lewis, ANP
Associate Director, Patient and Community Affairs
BMS Virology
777 Scudders Mill Road
Plainsboro, NJ 08536
Email: [email protected]
Phone: 609-897-4707
Fax: 609-897-5525

Michele Kofman, MPH
Patient and Community Affairs Manager, NYC/Northern NJ
Email: [email protected]
Phone: 1-800-492-7016 x 1409

Heshie Zinman
Patient and Community Affairs Manager, Northeast
Email: [email protected]
Phone: 1-800-492-7016 x 1423

Tom Millner
Patient and Community Affairs Manager, Southeast
Email: [email protected]
Phone: 1-800-492-7016 x 1415

Larry Wolf
Patient and Community Affairs Manager, Central States
Email: [email protected]
Phone: 1-800-492-7016 x 1422

Amy Valenzuela
Patient and Community Affairs Manager, Southwest
Email: [email protected]
Phone: 1-800-492-7016 x 1421

Steve Oxendine
Patient and Community Affairs Manager, Northwest
Email: [email protected]
Phone: 1-800-492-7016 x 1416

PRODUCT INFORMATION

1. FDA-Approved Products:

Nucleoside analog reverse transcriptase inhibitors: didanosine (ddI, Videx®, Videx® EC enteric coated), stavudine (d4T, Zerit®)
Non-nucleoside reverse transcriptase inhibitor: efavirenz (Sustiva®)
Antineoplastic agent (enhances ddI activity): hydroxyurea (Hydrea®)

2. Products in Clinical Trials:

Non-nucleoside reverse transcriptase inhibitor: BMS-083
Hepatitis B polymerase inhibitor: Entecavir

Web pages:

• Bristol-Myers Squibb Company, http://www.bms.com
• Sustiva, http://www.sustiva.com
• Videx EX, http://www.videxec.com/
• Zerit, http://www.zerit.com/

KEY PERSONNEL

BMS Virology, Plainsboro, NJ

• Jeff Hatfield, Sr. Vice President
• Tim Ravenscroft, Vice President, Strategy and Operations
• Antony Charles, Vice President, US Marketing
• Michael R. Stevens, PharmD, Vice President, US Medical Affairs

BMS Pharmaceutical Research Institute (PRI)

• Rich Colonno, MD, Vice President, Infectious Disease Drug Discovery
• Steve Schnittman, MD, Vice President, Full Development Team Champion, Atazanavir
• Deborah Dehertogh, MD, Vice President, Global Development Champion, Entecavir
• Nancy Ruiz, MD, Group Director, Clinical Design and Evaluation
• Michael Giordano, MD, Director, Clinical Research
• Elizabeth Cooney, MD, Associate Director, Clinical Research
• Helena Brett- Smith, MD, Associate Director, Clinical Research

Secure the Future

• Amadou Diarra, Senior Director

Revised September 11, 2003

Go to Main Page

E-mail the Coalition